Pharmaceutical care for patients with persistent asthma: Assessment of treatment compliance and use of inhaled medications;Atenção farmacêutica ao portador de asma persistente: Avaliação da aderência ao tratamento e da técnica de utilização dos medicamentos inalatórios

Jornal Brasileiro de Pneumologia

Volumn 36, Issue 1, 2010, Pages 14-22

  Santos, Daiane de Oliveira ^a   Martins, Maria Cleusa ^a   Cipriano, Sonia Lucena ^a   Pinto, Regina Maria Carvalho ^a   Cukier, Alberto ^a   Stelmach, Rafael ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Administration, inhalation; Asthma; Medication adherence; Metered dose inhalers; Pharmaceutical services

Indexed keywords

EID: 77749326527     PISSN: 18063713     EISSN: 18063713     Source Type: Journal    
DOI: 10.1590/s1806-37132010000100005     Document Type: Article

References (26)

1. Global Initiative for Asthma (GINA) [homepage on the Internet]. Bethesda: National Heart, Lung and Blood Institute. National Institutes of Health, US Department of Health and Human Services; c2000. [cited 2008 Mar 4]. Global Strategy for Asthma Management and Prevention updated 2007. Available from: http://www. ginasthma.org/
2. Basheti IA, Reddel HK, Armour CL, Bosnic-Anticevich SZ. Counseling about turbuhaler technique: needs assessment and effective strategies for community pharmacists. Respir Care. 2005;50(5):617-23.
3. Rio EM, Gallo PR, Siqueira AA. Asthma mortality in the city of São Paulo, Brazil [Article in Portuguese]. Rev Saude Publica. 2002;36(2):149-54.
4. Delgado AB, Lima ML. Contributo para a validação concorrente de uma medida de adesão aos tratamentos. Psic Saude Doenças. 2001;2(2):81-100.
5. Fiterman J, Mattos W, Cukier A, Pizzichinni M, Silva RF, Kahan F, et al. Acceptability, preference, tolerance and clinical efficacy of dipropionate beclomethasone delivered by two inhalation devices in chronic asthma patients: Clenil pulvinal® versus Miflasona Aerolizer® [Article in Portuguese]. J Bras Pneumol. 2004;30(5):413-8.
6. Eshel G, Raviv R, Ben-Abraham R, Barr J, Berkovitch M, Efrati O, et al. Inadequate asthma treatment practices and noncompliance in Israel. Pediatr Pulmonol. 2002;33(2):85-9.
7. Sherman J, Patel P, Hutson A, Chesrown S, Hendeles L. Adherence to oral montelukast and inhaled fluticasone in children with persistent asthma. Pharmacotherapy. 2001;21(12):1464-7.
8. Jones C, Santanello NC, Boccuzzi SJ, Wogen J, Strub P, Nelsen LM. Adherence to prescribed treatment for asthma: evidence from pharmacy benefits data. J Asthma. 2003;40(1):93-101.
9. Rand CS, Wise RA. Measuring adherence to asthma medication regimens. Am J Respir Crit Care Med. 1994;149(2 Pt 2):S69-76; discussion S77-8.
10. Hess DR. Metered-dose inhalers and dry powder inhalers in aerosol therapy. Respir Care. 2005;50(10):1376-83.
11. Allen SC, Ragab S. Ability to learn inhaler technique in relation to cognitive scores and tests of praxis in old age. Postgrad Med J. 2002;78(915):37-9.
12. Dolovich MB, Ahrens RC, Hess DR, Anderson P, Dhand R, Rau JL, et al. Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest. 2005;127(1):335-71.
13. Närhi U, Airaksinen M, Tanskanen P, Erlund H. Therapeutic outcomes monitoring by community pharmacists for improving clinical outcomes in asthma. J Clin Pharm Ther. 2000;25(3):177-83.
14. Prabhakaran L, Lim G, Abisheganaden J, Chee CB, Choo YM. Impact of an asthma education programme on patients' knowledge, inhaler technique and compliance to treatment. Singapore Med J. 2006;47(3):225-31.
15. Mehuys E, Van Bortel L, De Bolle L, Van Tongelen I, Annemans L, Remon JP, et al. Effectiveness of pharmacist intervention for asthma control improvement. Eur Respir J. 2008;31(4):790-9.
16. Farmacopéia Brasileira. São Paulo: Atheneu; 1988. pt 1, p. v.1.1-2.
17. Leal OM. Análise de fatores potencialmente agravantes da asma brônquica em pacientes tratados com corticoisteróides sistêmicos [dissertation]. São Paulo: Universidade de São Paulo; 1998.
18. Muniz JB, Padovani CR, Godoy I. Inalantes no tratamento da asma: avaliação do domínio das técnicas de uso por pacientes, alunos de medicina e médicos residentes. J Pneumol. 2003;29(2):75-81.
19. Chafin CC, Tolley EA, George CM, Demirkan K, Kuhl DA, Pugazhenthi M, et al. Gender differences in metereddose inhaler-spacer device technique. Pharmacotherapy. 2000;20(11):1324-7.
20. Kulkarni SP, Alexander KP, Lytle B, Heiss G, Peterson ED. Long-term adherence with cardiovascular drug regimens. Am Heart J. 2006;151(1):185-91.
21. Santos Pde M, D'Oliveira A Jr, Noblat Lde A, Machado AS, Noblat AC, Cruz AA. Predictors of adherence to treatment in patients with severe asthma treated at a referral center in Bahia, Brazil. J Bras Pneumol. 2008;34(12):995-1002.
22. Rabe KF, Pizzichini E, Ställberg B, Romero S, Balanzat AM, Atienza T, et al. Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: a randomized, double-blind trial. Chest. 2006;129(2):246-56.
23. Chrystyn H. The Diskus: a review of its position among dry powder inhaler devices. Int J Clin Pract. 2007;61(6):1022-36.
24. Crompton GK, Barnes PJ, Broeders M, Corrigan C, Corbetta L, Dekhuijzen R, et al. The need to improve inhalation technique in Europe: a report from the Aerosol Drug Management Improvement Team. Respir Med. 2006;100(9):1479-94.
25. Schulz M, Verheyen F, Mühlig S, Müller JM, Mühlbauer K, Knop-Schneickert E, et al. Pharmaceutical care services for asthma patients: a controlled intervention study. J Clin Pharmacol. 2001;41(6):668-76.
26. Cordina M, McElnay JC, Hughes CM. Assessment of a community pharmacy-based program for patients with asthma. Pharmacotherapy. 2001;21(10):1196-203.